| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | Aug 12, 2024 | Tempest Therapeutics, Inc. | 10% Owner | Sell | 20.0 | -787,999 | -18.35% | ✗ | $967K |
| Apr 20, 2018 | Apr 24, 2018 | CRISPR Therapeutics AG | 10% Owner | Sell | 18.8 | -601,994 | -12.81% | ✓ | $5.2M |